Website & contact details
- Website
Brancaster Pharma Limited
- Incorporated
- 15 August 2012 (14 years)
- Industry
- Wholesale of pharmaceutical goods (46460)
- Directors
- Alexander James Duckworth
- Owned by
- Accounts type
- Total exemption full
- Region
- South East
- Address
- The Office Heath View Ray LaneBlindley HeathLingfieldRH7 6LH
Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 March 2025
- Conf. stmt due
- 6 May 2027
- Last conf. stmt
- 22 April 2026
Officers 1 active
Officer details are public data from the Companies House register.
Duckworth, Alexander James
Director · Appointed 15 August 2012
British
Born August 1970 (56)
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 1 December 2022
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Right to appoint and remove directors (as a firm)
Private Limited Company
Reg. no. 14342465
Former controllers (3)
1 December 2022
Ceased Duck Hut Ltd — Owns 75–100% of shares
23 June 2022
Ceased Alexander James Duckworth — Owns 25–50% of shares
23 June 2022
Ceased Kimberley Maria Duckworth — Owns 25–50% of shares
Group structure 4 companies
Ownership group derived from the Companies House PSC register
Brancaster Pharma Limited This company Owns 75–100% of shares
Thistle Pharma Limited Owns 75–100% of shares
Your Products Limited Owns 50–75% of shares
Financials
Balance sheet as at 31 March 2025 · total exemption full accounts
- Net Assets
- £7,198,076
- Cash
- £2,764,463
- Debt Ratio
- 5%
- Current Ratio
- 20.1x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £531,439 | £531,365 | £531,260 | £231,438 | £188,138 | £188,415 |
| Current Assets | £7,016,508 | £6,790,353 | £5,877,225 | £10,620,856 | £10,156,235 | £7,906,630 |
| Debtors | £3,708,792 | £1,393,032 | £838,438 | £1,064,274 | £1,371,147 | £2,269,793 |
| Cash | £2,764,463 | £5,069,372 | £4,442,477 | £8,964,068 | £8,476,782 | £5,270,893 |
| Creditors (< 1 year) | £349,717 | £1,020,754 | £699,149 | £385,124 | £795,291 | £705,464 |
| Net Current Assets | £6,666,791 | £5,769,599 | £5,178,076 | £10,235,732 | £9,360,944 | £7,201,166 |
| Net Assets | £7,198,076 | £6,300,964 | £5,708,901 | £10,466,701 | £9,548,784 | £7,389,230 |
| Shareholder Funds | £7,198,076 | £6,300,964 | £5,708,901 | £10,466,701 | £9,548,784 | £7,389,230 |
What Brancaster Pharma say about themselves
“Brancaster Pharma Ltd: relief for patients who suffer from rarer conditions.”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 6 May 2026 | Director's details changed | |||
| 5 May 2026 | Confirmation statement with no updates | 22 April 2026 | ||
| 19 December 2025 | Total exemption full accounts | 31 March 2025 | ||
| 29 April 2025 | Confirmation statement with no updates | 22 April 2025 | ||
| 2 August 2024 | Total exemption full accounts | 31 March 2024 |
Other companies in this industry
Birmingham
Weybridge
Guildford
London
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →